Viewing Study NCT04255433


Ignite Creation Date: 2025-12-25 @ 3:02 AM
Ignite Modification Date: 2025-12-31 @ 11:03 AM
Study NCT ID: NCT04255433
Status: COMPLETED
Last Update Posted: 2025-08-24
First Post: 2020-02-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module